Emalex Biosciences

Emalex Biosciences is a biotechnology company focused on developing innovative treatments for central nervous system disorders, specifically targeting Tourette syndrome. The company is currently conducting late-stage clinical studies for a new class of drug aimed at patients with limited treatment options. Emalex is committed to providing relief fo... r individuals suffering from Tourette syndrome, addressing both the physical and emotional challenges associated with the condition. Their lead candidate has shown promising results in clinical trials, demonstrating statistical significance in efficacy for both pediatric and adult subjects.Read More